Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials • Medical Devices & Mechanical Engineering
19 pending office actions • 13 art units • 19 examiners • 0 of 19 (0%) have an AI response strategy ready • 19 patents granted in the last 365 days
The Board of Regents of the University of Nebraska currently manages 16 pending office actions within the Biotechnology & Pharmaceuticals technology area. These actions are distributed among 16 distinct examiners, meaning each pending matter is being evaluated by a different individual. This workload is spread across 11 distinct art units, indicating a broad range of technical specializations within the university's life sciences portfolio. The high number of 11 distinct art units suggests that the university's research covers many different facets of biotechnology and pharmaceuticals, requiring a sophisticated management strategy to handle the diverse technical requirements of 11 different groups.
FIX, THOMAS S is identified as the busiest examiner for the portfolio. This examiner is responsible for 1 pending office action, which is 1 of the 16 total actions currently pending for the institution. Because the 16 pending actions are spread across 16 distinct examiners, the prosecution risk is highly diversified. No single examiner's tendencies will significantly impact the overall success of the portfolio. The university's progress in securing intellectual property depends on the individual outcomes of 16 separate prosecution efforts across the 11 distinct art units.
Based on the USPTO statutory response window for each pending office action. 7 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 7 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 2 (11%) |
| §103 only | 8 (42%) |
| Double-patenting + other | 1 (5%) |
| Multi-statute (no §101) | 8 (42%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| FIX, THOMAS S | 1 | 72.1% | +16.3% |
| DAVIS, BRIAN J | 1 | 84.8% | -4.0% |
| GEMBEH, SHIRLEY V | 1 | 63.2% | +34.0% |
| AGGARWAL, SAHIL CHANDER | 1 | 100.0% | +0.0% |
| PACKARD, BENJAMIN J | 1 | 66.7% | +15.6% |
| RODRIGUEZ, RAYNA B | 1 | 33.6% | +19.2% |
| ALLEY, GENEVIEVE S | 1 | 60.3% | +48.2% |
| SHARMA, YASHITA | 1 | 81.8% | +24.6% |
| SUN, CAITLYN MINGYUN | 1 | 63.5% | +11.9% |
| DIETRICH, JOSEPH M | 1 | 80.8% | +8.6% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18493925 | SYSTEMS AND METHODS FOR TREATING AND INHIBITING WOUND INFECTIONS | DIETRICH, JOSEPH M | 112d overdue |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18386798 | MULTIFUNCTIONAL SOFT BIOELECTRONICS | SUN, CAITLYN MINGYUN | 24d overdue |
| 18600263 | NANOFIBER AND MICROFIBER HYBRID AEROGELS | ALLEY, GENEVIEVE S | 17d overdue |
| 18194664 | NANOFIBER COLLECTION DEVICES | VARGOT, MATHIEU D | 43d |
| 19210517 | SINGLE-ARM ROBOTIC DEVICE WITH COMPACT JOINT DESIGN AND RELATED SYSTEMS AND METHODS | FIX, THOMAS S | — |
| 18987189 | GROWTH FACTOR LOADED NANOFIBERS AND METHODS OF USE THEREOF | DAVIS, BRIAN J | — |
| 18846364 | METFORMIN NANOFORMULATIONS AND METHODS OF USE THEREOF | GEMBEH, SHIRLEY V | — |
| 18711139 | NOVEL INHIBITORS OF CLAUDIN-1 FOR THERAPEUTIC INTERVENTIONS | AGGARWAL, SAHIL CHANDER | — |
| 18399254 | AUTOMATED RETRIEVABLE HEMORRHAGE CONTROL SYSTEM | SHARMA, YASHITA | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 7 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18386798 | MULTIFUNCTIONAL SOFT BIOELECTRONICS | SUN, CAITLYN MINGYUN | 24d overdue |
| 18600263 | NANOFIBER AND MICROFIBER HYBRID AEROGELS | ALLEY, GENEVIEVE S | 17d overdue |
| 18699799 | REFILLABLE TISSUE ENGINEERED SCAFFOLDS | PACKARD, BENJAMIN J | 10d overdue |
| 19210517 | SINGLE-ARM ROBOTIC DEVICE WITH COMPACT JOINT DESIGN AND RELATED SYSTEMS AND METHODS | FIX, THOMAS S | — |
| 18846364 | METFORMIN NANOFORMULATIONS AND METHODS OF USE THEREOF | GEMBEH, SHIRLEY V | — |
| 18622241 | Methods for Administration and Methods for Treating Cardiovascular Diseases with Resiniferatoxin | RODRIGUEZ, RAYNA B | — |
| 18399254 | AUTOMATED RETRIEVABLE HEMORRHAGE CONTROL SYSTEM | SHARMA, YASHITA | — |
| Art Unit | Apps |
|---|---|
| 3618 | 1 |
| 1612 | 1 |
| 1617 | 1 |
| 3774 | 1 |
| 1795 | 1 |
| 3796 | 1 |
| 3783 | 1 |
| 1654 | 1 |
| 1611 | 1 |
| 1742 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19210517 | SINGLE-ARM ROBOTIC DEVICE WITH COMPACT JOINT DESIGN AND RELATED SYSTEMS AND METHODS | FIX, THOMAS S | 3618 | §101DP | Final Rejection | — | Pending | May 16, 2025 |
| 18987189 | GROWTH FACTOR LOADED NANOFIBERS AND METHODS OF USE THEREOF | DAVIS, BRIAN J | — | §102§103§112 | Non-Final OA | — | Pending | Dec 19, 2024 |
| 18846364 | METFORMIN NANOFORMULATIONS AND METHODS OF USE THEREOF | GEMBEH, SHIRLEY V | — | §102§103 | Non-Final OA | — | Pending | Sep 12, 2024 |
| 18711139 | NOVEL INHIBITORS OF CLAUDIN-1 FOR THERAPEUTIC INTERVENTIONS | AGGARWAL, SAHIL CHANDER | — | §102§112 | Non-Final OA | — | Pending | May 17, 2024 |
| 18699799 | REFILLABLE TISSUE ENGINEERED SCAFFOLDS | PACKARD, BENJAMIN J | 1612 | §103 | Non-Final OA | 10d overdue | Pending | Apr 09, 2024 |
| 18622241 | Methods for Administration and Methods for Treating Cardiovascular Diseases with Resiniferatoxin | RODRIGUEZ, RAYNA B | — | §103 | Non-Final OA | — | Pending | Mar 29, 2024 |
| 18600263 | NANOFIBER AND MICROFIBER HYBRID AEROGELS | ALLEY, GENEVIEVE S | 1617 | §102§103§112 | Final Rejection | 17d overdue | Pending | Mar 08, 2024 |
| 18399254 | AUTOMATED RETRIEVABLE HEMORRHAGE CONTROL SYSTEM | SHARMA, YASHITA | 3774 | §102§103 | Non-Final OA | — | Pending | Dec 28, 2023 |
| 18386798 | MULTIFUNCTIONAL SOFT BIOELECTRONICS | SUN, CAITLYN MINGYUN | 1795 | §103§112 | Non-Final OA | 24d overdue | Pending | Nov 03, 2023 |
| 18493925 | SYSTEMS AND METHODS FOR TREATING AND INHIBITING WOUND INFECTIONS | DIETRICH, JOSEPH M | 3796 | §103 | Non-Final OA | 112d overdue | Pending | Oct 25, 2023 |
| 18469022 | COMPUTATIONAL SYSTEM AND METHOD FOR DIAGNOSIS, PROGNOSIS, AND THERAPEUTICS OF CANCER PATIENTS USING SPATIAL-TEMPORAL TISSUE ARCHITECTURAL PROPERTIES | BAILEY, STEVEN WILLIAM | — | §101§102§103 | Non-Final OA | — | Pending | Sep 18, 2023 |
| 18281911 | CATHETER PLACEMENT DEVICES | GRAY, PHILLIP A | 3783 | §103 | Final Rejection | — | Pending | Sep 13, 2023 |
| 18278865 | Antimicrobial Peptides | JAUHARI, SACHI | 1654 | §103Other | Non-Final OA | — | Pending | Aug 25, 2023 |
| 18197905 | Methods for Administration and Methods for Treating Cardiovascular Diseases with Resiniferatoxin | BAEK, BONG-SOOK | 1611 | DPOther | Final Rejection | — | Pending | May 16, 2023 |
| 18194664 | NANOFIBER COLLECTION DEVICES | VARGOT, MATHIEU D | 1742 | §103§112 | Non-Final OA | 43d | Pending | Apr 03, 2023 |
| 17905407 | CRISPR/CAS9 SYSTEM FOR MULTISTRAIN HIV-1 TREATMENT | VIVLEMORE, TRACY ANN | 1638 | §103 | Non-Final OA | 28d | Pending | Aug 31, 2022 |
| 17681541 | LIGHTWEIGHT LIQUID METAL EMBEDDED ELASTOMER COMPOSITE | LING, DORIS | 1764 | §103 | Non-Final OA | — | Pending | Feb 25, 2022 |
| 17309435 | ANTIVIRAL PRODRUGS AND NANOFORMULATIONS THEREOF | SIMMONS, CHRIS E | 1622 | §103 | Final Rejection | 45d overdue | Pending | May 27, 2021 |
| 18819461 | COMPUTATIONAL SIMULATION PLATFORM FOR PLANNING OF INTERVENTIONAL PROCEDURES | TORRES, JOSE | — | §103§112 | Non-Final OA | — | Pending | Aug 29, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial